Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects
Active
- Assistance listing
- 93.185
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Grant awards
- 251 $3,675,701,311 in federal obligations
Program facts
- Assistance types
-
- Cooperative Agreement
- Block Grant
- Project Grant
- Treasury account
-
- 75-0943-0-1-550
- More information
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Centers for Disease Control and Prevention (CDC) funds research, demonstration projects, and public information and education activities on vaccine-preventable diseases and immunization programs under Assistance Listing 93.185, with the most recent award (Cooperative Agreement NH23IP922710 to Texas) disbursed July 1, 2025.
The program has awarded 251 grants totaling $3.68 billion in combined federal obligation since its inception in 2002, with activity concentrated in recent years: seven awards in 2024, six in 2023, three in 2021, and one in 2025. The funding landscape has remained relatively stable, with awards typically covering one to five-year periods of performance; initial funding covers the first 12 months, with non-competitive continuation available for up to five years subject to satisfactory recipient progress and fund availability.
Funded activities span vaccine delivery infrastructure, disease surveillance and outbreak response, vaccine effectiveness evaluation, vaccine confidence and demand campaigns, epidemiologic training and capacity building, and health equity improvements. Representative projects include strengthening state immunization programs to increase vaccination access and equity (Texas, $57.5 million); evaluating respiratory virus vaccine effectiveness in large diverse healthcare systems (multiple sites); developing outbreak analytics and disease modeling tools for public health response (academic centers, $27–44 million each); promoting vaccine confidence through trusted messengers and community health workers; and supporting global polio eradication modeling and immunization program capacity in low- and middle-income countries.
Funding is overwhelmingly concentrated in CDC, which obligated $3.79 billion across 249 awards (99 percent of award count). The assistance-type mix is predominantly Cooperative Agreements (172 awards, 69 percent) with smaller shares of Project Grants (53 awards, 21 percent) and Block Grants (26 awards, 10 percent). Typical award sizes range from $800 thousand to $3 million annually for state immunization programs and smaller research projects, with larger awards to national research networks and capacity-building organizations reaching $5–44 million over multi-year periods.
Multiple NOFOs are currently open or recently posted. RFA-IP-27-026 (posted July 28, 2026) seeks five cooperative agreement awards up to $1.8 million annually per site for the US Influenza Vaccine Effectiveness Network, conducting vaccine effectiveness surveillance and household transmission research; CDC-RFA-IP-26-0102 (posted August 1, 2025, due June 29, 2026) seeks to establish an influenza modeling and forecasting network to inform CDC's situational awareness and control strategies; and RFA-IP-25-111 (posted August 6, 2024, due February 6, 2025) supports rapid-cycle surveys of healthcare providers and the public on immunization issues. CDC-RFA-JG-27-0077, posted August 31, 2026, targets innovative disease modeling approaches to inform global polio eradication strategy.
Objective and description
- Objective
To assist states, political subdivisions of states, and other public and private nonprofit entities to conduct research, demonstration projects, and provide public information on vaccine-preventable diseases and conditions.
- Description
To assist states, political subdivisions of states, and other public and private nonprofit entities to conduct research, demonstration projects, and provide public information on vaccine-preventable diseases and conditions.
Eligibility
- Applicant eligibility
Under Section 317(k) of the Public Health Service Act: States, political subdivision of states, and other public and private nonprofit entities.
- Beneficiary eligibility
Under Section 317(k) of the Public Health Service Act: States, political subdivisions of states, and other public and private nonprofit entities.
- Uses of assistance
Project funds may be used for costs associated with organizing and conducting these projects, and in certain circumstances, for purchasing vaccine. Requests for direct assistance (i.e., "in lieu of cash") for personnel, vaccines, and other forms of direct assistance will be considered. Funds may not be used to supplant existing immunization program activities.
- Length and time phasing of assistance
Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient.
How to apply
- Criteria for selecting proposals
Applications will be evaluated on the review criteria described in the Notice of Funding Opportunity Announcements (NOFOs). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of CDC.
- Award procedure
After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any.
- Deadlines
Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance.
- Renewals
Cooperative agreement period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
Grant opportunities
Show 39 more
Latest 49 listed here. See the rest on GovTribe.
Grant awards
Latest 10 of 251 listed here. See the rest on GovTribe.
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | World Health Organization | $599,255,024 | 16% |
| 2 | Unicef | $439,869,336 | 12% |
| 3 | Ohio Department Of Health | $338,850,112 | 9% |
| 4 | Washington State Department Of Health | $254,840,508 | 7% |
| 5 | Indiana Department Of Health | $198,842,976 | 5% |
| 6 | State Of Wisconsin Department Of Health Services | $188,279,632 | 5% |
| 7 | Oregon Health Authority-Public Health | $126,384,480 | 3% |
| 8 | Health Services Kentucky Cabinet For | $125,186,504 | 3% |
| 9 | The Task Force For Global Health, Inc. | $116,043,808 | 3% |
| 10 | Kansas Department Of Health & Environment | $102,541,192 | 3% |
10 of 108 recipients listed here. See the rest on GovTribe.
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2026 | -$68,361,387 |
| FY2025 | $40,047,699 |
| FY2024 | $225,124,866 |
| FY2023 | $270,756,211 |
| FY2022 | $330,385,395 |
| FY2021 | $226,680,264 |
| FY2020 | $230,890,092 |
| FY2019 | $120,106,741 |
| FY2018 | $80,696,279 |
| FY2017 | $127,400,963 |
| FY2016 | $125,127,682 |
| FY2015 | $123,121,394 |
| FY2014 | $122,144,504 |
| FY2013 | $106,826,706 |
| FY2012 | $128,440,551 |
| FY2011 | $132,692,025 |
| FY2010 | $143,750,991 |
| FY2009 | $133,529,524 |
| FY2008 | $186,491,252 |
| FY2007 | $10,198,043 |
| FY2006 | $1,374,558 |
| FY2005 | $577,967 |
| FY2004 | $95,000 |
| FY2003 | $5,444,956 |
| FY2002 | -$681,319 |
Show all 25
Quick answers
What is Assistance Listing 93.185?
Assistance Listing 93.185 is Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects, a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services).
What is the CFDA number for Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects?
Its CFDA number is 93.185: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.185 awarded?
251 grant awards under 93.185 have obligated $3,675,701,311 in federal funds to 108 recipients.
Who receives the most funding from 93.185?
The recipients obligated the most under Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects are World Health Organization ($599,255,024), Unicef ($439,869,336) and Ohio Department Of Health ($338,850,112).
How much did 93.185 obligate in fiscal year 2025?
Grants under 93.185 obligated $40,047,699 in federal funds in fiscal year 2025.
Are there open grant opportunities under 93.185?
2 of the latest 49 opportunities under 93.185 are open or forecasted. The latest, Informing global polio eradication efforts through innovative modeling approaches, was posted on August 31, 2026.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program